Search research articles
Contact Us
Filters
Showing results (181-190 of 397) with videos related to
Page
of 40
Sort By:
Organic Electronics
|
April 16, 2019
Electronic properties and structure of single crystal perylene
S J Pookpanratana, K P Goetz, E G Bittle, et al.
Breast Cancer Research : BCR
|
March 12, 2011
Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
Xianglin Wu, Malayannan Subramaniam, Sarah B Grygo, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
February 18, 2022
Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)
Marwan K Tayeh, Andrea Gaedigk, Matthew P Goetz, et al.
International Journal of Oncology
|
June 28, 2014
Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells
Mateusz Opyrchal, Jeffrey L Salisbury, Ianko Iankov, et al.
Molecular Therapy Oncolytics
|
December 2, 2022
Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer
Marshall D Behrens, Robert J Stiles, Gennett M Pike, et al.
The Oncologist
|
June 15, 2020
Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2- Advanced Breast Cancer
Matthew P Goetz, Miguel Martin, Eriko Tokunaga, et al.
Breast Cancer Research : BCR
|
August 24, 2021
Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial
Patrick Neven, Hope S Rugo, Sara M Tolaney, et al.
Journal of Materials Chemistry. C
|
June 26, 2023
Remarkable performance recovery in highly defective perovskite solar cells by photo-oxidation
Katelyn P Goetz, Fabian T F Thome, Qingzhi An, et al.
Oncotarget
|
June 25, 2019
Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall
Ann M Moyer, Jia Yu, Jason P Sinnwell, et al.
Clinical Colorectal Cancer
|
August 8, 2007
Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248
Steven R Alberts, George P Kim, Michelle R Mahoney, et al.
Page
of 40
Search research articles
Search
Showing results (181-190 of 397) with videos related to
Sort By:
Page
of 40
Organic Electronics
|
April 16, 2019
Electronic properties and structure of single crystal perylene
S J Pookpanratana, K P Goetz, E G Bittle, et al.
Breast Cancer Research : BCR
|
March 12, 2011
Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
Xianglin Wu, Malayannan Subramaniam, Sarah B Grygo, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
February 18, 2022
Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)
Marwan K Tayeh, Andrea Gaedigk, Matthew P Goetz, et al.
International Journal of Oncology
|
June 28, 2014
Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells
Mateusz Opyrchal, Jeffrey L Salisbury, Ianko Iankov, et al.
Molecular Therapy Oncolytics
|
December 2, 2022
Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer
Marshall D Behrens, Robert J Stiles, Gennett M Pike, et al.
The Oncologist
|
June 15, 2020
Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2- Advanced Breast Cancer
Matthew P Goetz, Miguel Martin, Eriko Tokunaga, et al.
Breast Cancer Research : BCR
|
August 24, 2021
Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial
Patrick Neven, Hope S Rugo, Sara M Tolaney, et al.
Journal of Materials Chemistry. C
|
June 26, 2023
Remarkable performance recovery in highly defective perovskite solar cells by photo-oxidation
Katelyn P Goetz, Fabian T F Thome, Qingzhi An, et al.
Oncotarget
|
June 25, 2019
Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall
Ann M Moyer, Jia Yu, Jason P Sinnwell, et al.
Clinical Colorectal Cancer
|
August 8, 2007
Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248
Steven R Alberts, George P Kim, Michelle R Mahoney, et al.
Page
of 40